Patient-reported outcome measures in a population of medically indigent patients with systemic lupus erythematosus in Puerto Rico

被引:2
作者
Rodriguez-Rivera, Diana V. [1 ]
Rodriguez-Navedo, Yerania [1 ]
Nieves-Plaza, Mariely [2 ]
Vila, Luis M. [1 ]
机构
[1] Univ Puerto Rico, Div Rheumatol, Dept Med, Med Sci Campus,POB 365067, San Juan, PR 00936 USA
[2] San Juan Bautista Sch Med, Grad Programs, Caguas, PR USA
关键词
Systemic lupus erythematosus; patient-reported outcomes; quality of life; underserved population; Puerto Rico;
D O I
10.1177/2050312116670927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine patient-reported outcomes measures in indigent patients with systemic lupus erythematosus receiving their healthcare through the Puerto Rico government managed care system and compare these measures with non-indigent patients treated in a private fee-for-service setting. Methods: A cross-sectional study was conducted in a cohort of 98 Puerto Ricans with systemic lupus erythematosus. Patients from the public group (n = 40) were treated in a university-based specialized systemic lupus erythematosus clinic and the private group (n = 58) in a community-based rheumatology practice. Demographic and clinical features and patient-reported outcomes measures per LupusPRO instrument were determined. LupusPRO captures quality-of-life measures in 12 domains. Differences among study groups were examined using chi-square, Fisher's exact, t-tests, and the Wilcoxon signed-rank test. Results: The mean (standard deviation) age of the study population was 44.9 (12.0) years; 94 (95.9%) were women. Patients in the public setting were younger and were more likely to have renal disease and elevated anti-double-stranded DNA antibodies, and being treated with azathioprine and cyclophosphamide. Patients from the public sector were more likely to have better quality-of-life measures in the LupusPRO domains of pain/vitality and coping. No significant differences were observed for the domains of lupus symptoms, physical health, emotional health, body image, cognition, procreation, lupus medications, desires/goals, social support, and satisfaction with medical care. Conclusion: Despite having a lower socioeconomic status and worse clinical status, systemic lupus erythematosus patients from the public sector had equal or better patient-reported outcomes measures than those treated in the private setting. This favorable outcome may be associated with the comprehensive healthcare received by these patients in a specialized lupus clinic.
引用
收藏
页数:5
相关论文
共 50 条
[41]   Patient-Reported Quality-of-Life Outcome Measures in the Thyroid Cancer Population [J].
Roth, Eve M. ;
Lubitz, Carrie C. ;
Swan, John Shannon ;
James, Benjamin C. .
THYROID, 2020, 30 (10) :1414-1431
[42]   Patient-reported experience with patient-reported outcome measures in adult patients seen in rheumatology clinics [J].
Lapin, Brittany R. ;
Honomichl, Ryan ;
Thompson, Nicolas ;
Rose, Susannah ;
Abelson, Abby ;
Deal, Chad ;
Katzan, Irene L. .
QUALITY OF LIFE RESEARCH, 2021, 30 (04) :1073-1082
[43]   Patient-reported experience with patient-reported outcome measures in adult patients seen in rheumatology clinics [J].
Brittany R. Lapin ;
Ryan Honomichl ;
Nicolas Thompson ;
Susannah Rose ;
Abby Abelson ;
Chad Deal ;
Irene L. Katzan .
Quality of Life Research, 2021, 30 :1073-1082
[44]   Patient-Reported Outcomes (Pros) and Patient-Reported Outcome Measures (Proms) [J].
Weldring, Theresa ;
Smith, Sheree M. S. .
HEALTH SERVICES INSIGHTS, 2013, 6 :61-68
[45]   Impact of pulmonary disease on patient-reported outcomes and patient-performed functional testing in systemic lupus erythematosus [J].
Fidler, L. ;
Keen, K. J. ;
Touma, Z. ;
Mittoo, S. .
LUPUS, 2016, 25 (09) :1004-1011
[46]   Patient-reported outcome measures in urology [J].
Narang, Gopal L. ;
Pannell, Stephanie C. ;
Laviana, Aaron A. ;
Huen, Kathy H. Y. ;
Izard, Jason ;
Smith, Angela B. ;
Bergman, Jonathan .
CURRENT OPINION IN UROLOGY, 2017, 27 (04) :366-374
[47]   Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures [J].
Robin Arcani ;
Elisabeth Jouve ;
Laurent Chiche ;
Noémie Jourde-Chiche .
Clinical Rheumatology, 2023, 42 :1555-1563
[48]   CATEGORIZATION OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS USING DISEASE ACTIVITY, PATIENT-REPORTED OUTCOMES AND TRANSCRIPTOMIC SIGNATURES [J].
Arcani, R. ;
Jouve, E. ;
Chiche, L. ;
Jourde-Chiche, N. .
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 :1062-1063
[49]   Patient-Reported Outcome Measures in Endometriosis [J].
Nicolas-Boluda, Alba ;
Oppenheimer, Anne ;
Bouaziz, Jerome ;
Fauconnier, Arnaud .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
[50]   Patient-Reported Outcome Measures as Complementary Information to Clinician-Reported Outcome Measures in Patients With Psoriasis [J].
Barbieri, John S. ;
Gelfand, Joel M. .
JAMA DERMATOLOGY, 2021, 157 (10) :1236-1237